This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2023-2024.
Company Filing History:
Years Active: 2023-2024
Title: Mary Haas: Innovator in Liver Disease Treatment
Introduction
Mary Haas is a prominent inventor based in Tarrytown, NY (US). She has made significant contributions to the field of medicine, particularly in the treatment of liver diseases. With a total of 2 patents to her name, her work is paving the way for innovative therapeutic approaches.
Latest Patents
Mary Haas's latest patents focus on the treatment of liver diseases using cell death inducing DFFA like effector B (CIDEB) inhibitors. The present disclosure provides methods of treating subjects with liver disease and methods of identifying subjects at an increased risk of developing liver disease. These advancements are crucial for improving patient outcomes and enhancing the understanding of liver-related health issues.
Career Highlights
Mary Haas is currently employed at Regeneron Pharmaceuticals, Inc., where she continues to push the boundaries of medical research. Her work is characterized by a commitment to developing effective treatments that address critical health challenges.
Collaborations
Mary collaborates with esteemed colleagues, including Niek Verweij and Luca Andrea Lotta. These partnerships enhance the research environment and contribute to the innovative solutions being developed at Regeneron Pharmaceuticals.
Conclusion
Mary Haas is a dedicated inventor whose work in liver disease treatment is making a significant impact in the medical field. Her innovative approaches and collaborations are essential for advancing healthcare solutions.